Platinum Investment Management LTD Biogen Inc. Transaction History

Platinum Investment Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $4.64 Million - $5.86 Million	-21,880 Reduced 91.09%	2,140 $461,000
Q4 2023 Feb 13, 2024	SELL	$222.59 - $267.94 $5,342 - $6,430	-24 Reduced 0.1%	24,020 $6.22 Million
Q2 2023 Aug 10, 2023	BUY	$275.25 - $318.06 $972,458 - $1.12 Million	3,533 Added 17.22%	24,044 $6.85 Million
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $675,522 - $769,731	-2,633 Reduced 11.38%	20,511 $5.7 Million
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $5.84 Million - $7.1 Million	23,144 New	23,144 $6.41 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.